Deze pagina is automatisch vertaald en de nauwkeurigheid van de vertaling kan niet worden gegarandeerd. Raadpleeg de Engelse versie voor een brontekst.

Language Outcomes in Deaf Children

16 november 2026 bijgewerkt door: The University of Tennessee, Knoxville

Pre- en post-descriptieve gegevens van taalresultaten bij dove kinderen

The goal of this single-arm, non-randomized clinical trial is to learn how deaf children's signed language discourse changes over the course of a school year while receiving their usual educational instruction. The study focuses on deaf children in PreKindergarten through Grade 3 who use signed language. The main questions it aims to answer are: Do deaf children show growth in signed expression from the beginning to the end of the school year? How does growth in signed expression vary? Participants will take part in their regular classroom instruction as provided by their school. They will create signed language videos in response to three prompts (narrative, informational, and opinion) at the beginning and end of the school year. They will have their signing samples scored using a standardized rubric for signed language discourse.

Studie Overzicht

Toestand

Beëindigd

Gedetailleerde beschrijving

This study was conducted as a multisite, single-arm, non-randomized pretest-posttest cohort trial examining change in discourse-level signed expression among deaf children across one academic year. All participants received their usual educational instruction as delivered in their classrooms. This naturally occurring educational instruction constituted the study intervention. No alternative instructional conditions or comparison groups were included. The study was designed to evaluate change over time within a single study arm receiving standard educational practice. Data were collected at two time points with a pretest at the beginning of the academic year and a posttest at the end of the academic year. At each time point, children completed three expressive language tasks representing narrative, informational, and opinion discourse types. Teachers followed a standardized administration protocol to ensure comprehension of prompts, provide planning time, and support independent production of signed responses. Signed language samples were recorded using classroom-based video equipment routinely used for instruction. Identical procedures were used at pretest and posttest to support consistency of measurement across time. Signing samples were scored using the Signed Language Composition Assessment (SLCA), a discourse-based rubric developed for signed language. Each sample received trait-level scores for Orientation to Purpose, Idea Development, and Length and Organization, rated on a six-point scale with genre-specific behavioral anchors adapted from established discourse and writing frameworks. Two raters independently scored 20% of the samples to ensure interrater reliability. Scores were considered in agreement if identical or differing by no more than 0.5 points. Discrepancies were resolved through a structured consensus process involving joint review of relevant video segments and discussion of scoring anchors. Trait-level and total scores at pretest and posttest formed the basis for all analyses. Child demographic and language background data were collected through a teacher-completed online survey during the academic year. Variables included age, grade, race/ethnicity, and gender/sex. The analytic approach focused on within-arm change over time to describe patterns of signed language growth under usual educational practice. Growth in signed expression from pretest to posttest was examined across grades and discourses. The study was designed to document change over time in signed language outcomes during routine educational instruction and establishes developmental benchmarks for discourse-level signed expression to inform future controlled and randomized trials.

Studietype

Observationeel

Inschrijving (Werkelijk)

181

Contacten en locaties

In dit gedeelte vindt u de contactgegevens van degenen die het onderzoek uitvoeren en informatie over waar dit onderzoek wordt uitgevoerd.

Studie Locaties

    • Tennessee
      • Knoxville, Tennessee, Verenigde Staten, 37996
        • University of Tennessee, Knoxville

Deelname Criteria

Onderzoekers zoeken naar mensen die aan een bepaalde beschrijving voldoen, de zogenaamde geschiktheidscriteria. Enkele voorbeelden van deze criteria zijn iemands algemene gezondheidstoestand of eerdere behandelingen.

Geschiktheidscriteria

Leeftijden die in aanmerking komen voor studie

4 jaar tot 10 jaar (Kind)

Accepteert gezonde vrijwilligers

Nee

Geslachten die in aanmerking komen voor studie

Allemaal

Bemonsteringsmethode

Niet-waarschijnlijkheidssteekproef

Studie Bevolking

Deaf children between 4 and 10 years old attending deaf education programs

Beschrijving

Inclusion Criteria:

  • Deaf children between 4 and 10 years old attending deaf education programs

Exclusion Criteria:

  • Non-deaf children

Studie plan

Dit gedeelte bevat details van het studieplan, inclusief hoe de studie is opgezet en wat de studie meet.

Hoe is de studie opgezet?

Ontwerpdetails

  • Observatiemodellen: COHORT
  • Tijdsperspectieven: PROSPECTIVE

Cohorten en interventies

Groep / Cohort
Interventie / Behandeling
Deaf children

Deaf children attending deaf education programs

Deaf children are receiving business-as-usual instruction in sign language in deaf education programs.

Wat meet het onderzoek?

Primaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Sign Language Skills
Tijdsspanne: From enrollment to the end of treatment 9 academic months later.

Deaf children's sign language skills will be evaluated using discourse-based measures. Responses to language prompts will be scored with the Sign Language Complexity Assessment (SLCA). The SLCA rates three discourse traits-orientation to purpose, idea development, and organization - on a scale from 0 (no expression) to 6 (multi-paragraph expression). Higher scores indicate more advanced sign language development.

From enrollment to the end of treatment 9 academic months later.

Secundaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Written Language Skills
Tijdsspanne: From enrollment to the end of treatment 9 academic months later.

Deaf children's written language skills will be evaluated using discourse-based measures. Responses to language prompts will be scored with the parallel writing measure for Sign Language Complexity Assessment (SLCA). The SLCA rates three discourse traits -orientation to purpose, idea development, and organization - on a scale from 0 (no expression) to 6 (multi-paragraph expression). Higher scores indicate more advanced written language development.

From enrollment to the end of treatment 9 academic months later.

Medewerkers en onderzoekers

Hier vindt u mensen en organisaties die betrokken zijn bij dit onderzoek.

Publicaties en nuttige links

De persoon die verantwoordelijk is voor het invoeren van informatie over het onderzoek stelt deze publicaties vrijwillig ter beschikking. Dit kan gaan over alles wat met het onderzoek te maken heeft.

Studie record data

Deze datums volgen de voortgang van het onderzoeksdossier en de samenvatting van de ingediende resultaten bij ClinicalTrials.gov. Studieverslagen en gerapporteerde resultaten worden beoordeeld door de National Library of Medicine (NLM) om er zeker van te zijn dat ze voldoen aan specifieke kwaliteitscontrolenormen voordat ze op de openbare website worden geplaatst.

Bestudeer belangrijke data

Studie start (Werkelijk)

1 augustus 2024

Primaire voltooiing (Werkelijk)

30 september 2025

Studie voltooiing (Werkelijk)

30 september 2025

Studieregistratiedata

Eerst ingediend

4 december 2024

Eerst ingediend dat voldeed aan de QC-criteria

4 december 2024

Eerst geplaatst (Werkelijk)

9 december 2024

Updates van studierecords

Laatste update geplaatst (Werkelijk)

17 november 2026

Laatste update ingediend die voldeed aan QC-criteria

16 november 2026

Laatst geverifieerd

1 november 2026

Meer informatie

Termen gerelateerd aan deze studie

Andere studie-ID-nummers

  • 478856
  • R21DC021024 (Subsidie/contract van de Amerikaanse NIH)

Plan Individuele Deelnemersgegevens (IPD)

Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?

JA

Beschrijving IPD-plan

Under a data-sharing agreement that is in compliance with the internal policy at UTK, non-identifying data can be shared with other researchers for a minimum of 10 years on the University of Tennessee Research and Creative Exchange (TRACE). The raw data consists of videos of teachers, which will not be shared to maintain confidentiality. The processed data will be in the form of percentages for individual teachers across an academic year documented in a .csv file (Excel). Center for Open Science Foundation (OSF) is a free and open source project management tool that supports researchers throughout their entire project lifecycle. OSF also allows people to locate this data through project names, author names, and study keywords.

IPD-tijdsbestek voor delen

December, 2026 to December, 2036

IPD-toegangscriteria voor delen

Researchers may contact the principal investigator for additional supporting information not available on OSF.

IPD delen Ondersteunend informatietype

  • LEERPROTOCOOL
  • ANALYTIC_CODE
  • MVO

Bestudeer gegevens/documenten

  1. Open Science Framework
    Informatie opmerkingen:

    The study's de-identified individual participant data (IPD) include student-level pre- and post-assessment outcomes, demographic variables, and relevant instructional context measures. Supporting materials include data dictionaries, scoring protocols, and documentation of analytic procedures. These materials are available through an OSF project link.

Informatie over medicijnen en apparaten, studiedocumenten

Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel

Nee

Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct

Nee

Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .

Abonneren